LyondellBasell Industries N.V.LYB
NYSE•Basic Materials•Specialty Chemicals
LyondellBasell Industries N.V. operates as a chemical company in the United States, Germany, China, Mexico, Italy, Japan, France, Poland, the Netherlands, and internationally. It operates in five segments: Olefins and PolyolefinsAmericas; Olefins and PolyolefinsEurope, Asia, International; Intermediates and Derivatives; Advanced Polymer Solutions; and Technology. The company produces and markets olefins and co-products, such as ethylene, aromatics, propylene and butadiene; polyolefins; polyethylene; polypropylene homopolymers and copolymers; propylene oxide and derivatives; oxyfuels and related products; and intermediate chemicals, such as styrene monomer and acetyls. It also produces and markets compounding and solutions, including polypropylene compounds, engineered plastics, masterbatches, and engineered composites and colors. In addition, it develops and licenses chemical and polyolefin process technologies; and manufactures and sells polyolefin catalysts and serves food packaging, home furnishings, automotive components, and paints and coatings applications. LyondellBasell Industries N.V. was incorporated in 2009 and is headquartered in London, the United Kingdom.
LyondellBasell Industries NV (LYB) reported trailing twelve months revenue of $29.67B as of March 2026, a 22.0% decline year-over-year. Quarterly revenue reached $7.20B, reflecting a contraction in sales.
LyondellBasell Industries NV reported a TTM net loss of $790.00M, with quarterly EBITDA of $581.00M. The operating margin expanded from 1.5% to 3.3%, suggesting improving cost efficiency and pricing discipline.
The spread between operating margin (3.3%) and net margin (1.7%) indicates tight cost control with minimal non-operating drag. Net margin has narrowed from 2.3% a year ago, reflecting increased costs or interest expense.
LYB trades at a P/S of 0.9x. The price-to-book ratio of 2.7x reflects a moderate premium to book value.
The company reported negative free cash flow of $-538.00M, indicating cash consumption over the period. The balance sheet shows $33.96B in total assets with $11.23B in long-term debt against $10.04B in stockholders equity for a debt-to-equity ratio of 1.1. Data based on the most recent quarterly reports.
Competitive analysis based on 21 quarters of fundamental data
Operating margins are under pressure, averaging 1.0%. The business may lack pricing power or face rising costs.'
ROE is low or negative, suggesting limited competitive advantage or capital allocation challenges.
5 of the last 8 quarters generated positive FCF. The company generally funds itself but has occasional cash consumption quarters.
Revenue has been flat or declining over recent quarters, which may indicate eroding demand or competitive pressure.
Data-driven red flags and warnings across 21 quarters
Operating margins dropped 131.8% over recent quarters — a sharp decline suggesting serious cost or pricing challenges.
FCF consistently trails net income (avg -2.6x) — earnings may be inflated by non-cash items or aggressive accounting.
Debt-to-equity has risen 28.7% recently — increasing financial risk even if the current ratio is manageable.
TTM revenue has contracted 20.7% — significant decline indicating deteriorating demand.
FCF turned negative in 3 of the last 8 quarters — occasional cash consumption.
Share count is stable — no significant dilution or buyback activity.
Quarterly standardized metrics.
Stock price and market valuation
Revenue and earnings growth across quarters
Assets, cash, debt, and leverage
Price multiples and return ratios
Operating efficiency and return metrics
Free cash flow, earnings quality, and capital allocation